To further verify the identified target genes that showed significant changes in DE and DM patterns in response to the combination treatment, we evaluated the expression of Pdx1, Tmem132d, Get4, Rpl13 and Ndufa1 genes in mouse mammary tumors using qRT-PCR. The gene discussed is TMEM132D; the disease is breast cancer.